Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 25
Filter
Add more filters










Publication year range
1.
J Pathol ; 259(3): 264-275, 2023 03.
Article in English | MEDLINE | ID: mdl-36426826

ABSTRACT

We recently demonstrated that normal memory B lymphocytes carry a substantial number of de novo mutations in the genome. Here, we performed exome-wide somatic mutation analyses of bona fide autoreactive rheumatoid factor (RF)-expressing memory B cells retrieved from patients with SjÓ§gren's syndrome (SS). The amount and repertoire of the de novo exome mutations of RF B cells were found to be essentially different from those detected in healthy donor memory B cells. In contrast to the mutation spectra of normal B cells, which appeared random and non-selected, the mutations of the RF B cells were greater in number and enriched for mutations in genes also found mutated in B-cell non-Hodgkin lymphomas. During the study, one of the SS patients developed a diffuse large B-cell lymphoma (DLBCL) out of an RF clone that was identified 2 years earlier in an inflamed salivary gland biopsy. The successive oncogenic events in the RF precursor clone and the DLBCL were assessed. In conclusion, our findings of enhanced and selected genomic damage in growth-regulating genes in RF memory B cells of SS patients together with the documented transformation of an RF-precursor clone into DLBCL provide unique novel insight into the earliest stages of B-cell derailment and lymphomagenesis. © 2022 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.


Subject(s)
Lymphoma, Large B-Cell, Diffuse , Sjogren's Syndrome , Humans , Sjogren's Syndrome/genetics , Sjogren's Syndrome/complications , Memory B Cells , Rheumatoid Factor , Mutation , Lymphoma, Large B-Cell, Diffuse/genetics
2.
Front Immunol ; 10: 572, 2019.
Article in English | MEDLINE | ID: mdl-30972067

ABSTRACT

The rapid evolution of porcine reproductive and respiratory syndrome viruses (PRRSV) poses a major challenge to effective disease control since available vaccines show variable efficacy against divergent strains. Knowledge of the antigenic targets of virus-neutralizing antibodies that confer protection against heterologous PRRSV strains would be a catalyst for the development of next-generation vaccines. Key to discovering these epitopes is the isolation of neutralizing monoclonal antibodies (mAbs) from immune pigs. To address this need, we sought to establish systems to enable the isolation of PRRSV neutralizing porcine mAbs. We experimentally produced a cohort of immune pigs by sequential challenge infection with four heterologous PRRSV strains spanning PRRSV-1 subtypes and PRRSV species. Whilst priming with PRRSV-1 subtype 1 did not confer full protection against a subsequent infection with a PRRSV-1 subtype 3 strain, animals were protected against a subsequent PRRSV-2 infection. The infection protocol resulted in high serum neutralizing antibody titers against PRRSV-1 Olot/91 and significant neutralization of heterologous PRRSV-1/-2 strains. Enriched memory B cells isolated at the termination of the study were genetically programmed by transduction with a retroviral vector expressing the Bcl-6 transcription factor and the anti-apoptotic Bcl-xL protein, a technology we demonstrated efficiently converts porcine memory B cells into proliferating antibody-secreting cells. Pools of transduced memory B cells were cultured and supernatants containing PRRSV-specific antibodies identified by flow cytometric staining of infected MARC-145 cells and in vitro neutralization of PRRSV-1. Collectively, these data suggest that this experimental system may be further exploited to produce a panel of PRRSV-specific mAbs, which will contribute both to our understanding of the antibody response to PRRSV and allow epitopes to be resolved that may ultimately guide the design of immunogens to induce cross-protective immunity.


Subject(s)
Antibodies, Monoclonal/immunology , Antibodies, Neutralizing/immunology , Antibodies, Viral/immunology , Porcine respiratory and reproductive syndrome virus/immunology , Viral Vaccines/immunology , Animals , Antibodies, Neutralizing/blood , Antibodies, Viral/blood , B-Lymphocytes/immunology , Cell Line , Epitopes/genetics , Immunologic Memory/genetics , Immunologic Memory/immunology , Neutralization Tests , Porcine Reproductive and Respiratory Syndrome/immunology , Porcine Reproductive and Respiratory Syndrome/therapy , Proto-Oncogene Proteins c-bcl-6/genetics , Swine , bcl-X Protein/genetics
3.
Arthritis Rheumatol ; 71(3): 340-350, 2019 03.
Article in English | MEDLINE | ID: mdl-30277007

ABSTRACT

OBJECTIVE: Anti-citrullinated protein antibodies (ACPAs) are a hallmark of rheumatoid arthritis (RA). Aside from autoantibody production, the function of autoantigen-specific B cells remains poorly understood in the context of this disease. This study set out to elucidate autoantigen-specific B cell functions through the isolation and immortalization of unique citrullinated protein/peptide (CP)-reactive B cell clones from RA patients. METHODS: B cell clones from either the blood or synovial fluid of cyclic citrullinated peptide 2 (CCP2) antibody-positive RA patients were immortalized by genetic reprogramming with Bcl-6 and Bcl-xL. Enzyme-linked immunosorbent assay and flow cytometry were used to identify CCP2-reactive clones and to further characterize surface marker and cytokine expression as well as B cell receptor signaling competence. Global gene expression profiles were interrogated by RNA sequencing. RESULTS: Three unique CP-reactive memory B cell clones were generated from the blood or synovial fluid of 2 RA patients. CP-reactive memory B cells did not appear to be broadly cross-reactive, but rather had a fairly restricted epitope recognition profile. These clones were able to secrete both pro- and antiinflammatory cytokines and had a unique surface profile of costimulatory molecules and receptors, including CD40 and C5a receptor type 1, when compared to non-CP-reactive clones from the same patient. In addition, CP-reactive clones bound citrullinated protein, but not native protein, and could mobilize calcium in response to antigen binding. CONCLUSION: CP-reactive memory B cells comprise a rare, seemingly oligoclonal population with restricted epitope specificity and distinct phenotypic and molecular characteristics suggestive of antigen-presenting cells. Cloning by genetic reprogramming opens new avenues to study the function of autoreactive memory B cells, especially in terms of antigen processing, presentation, and subsequent T cell polarization.


Subject(s)
Anti-Citrullinated Protein Antibodies/immunology , Arthritis, Rheumatoid/immunology , Autoantigens/immunology , B-Lymphocytes/immunology , Peptides, Cyclic/immunology , Autoantibodies/immunology , Clone Cells/immunology , Cytokines/metabolism , Enzyme-Linked Immunosorbent Assay , Epitopes/immunology , Humans , Synovial Fluid/immunology
4.
Sci Rep ; 7(1): 15307, 2017 11 10.
Article in English | MEDLINE | ID: mdl-29127322

ABSTRACT

The sodium taurocholate co-transporting polypeptide (NTCP, SLC10A1) is the main hepatic transporter of conjugated bile acids, and the entry receptor for hepatitis B virus (HBV) and hepatitis delta virus (HDV). Myrcludex B, a synthetic peptide mimicking the NTCP-binding domain of HBV, effectively blocks HBV and HDV infection. In addition, Myrcludex B inhibits NTCP-mediated bile acid uptake, suggesting that also other NTCP inhibitors could potentially be a novel treatment of HBV/HDV infection. This study aims to identify clinically-applied compounds intervening with NTCP-mediated bile acid transport and HBV/HDV infection. 1280 FDA/EMA-approved drugs were screened to identify compounds that reduce uptake of taurocholic acid and lower Myrcludex B-binding in U2OS cells stably expressing human NTCP. HBV/HDV viral entry inhibition was studied in HepaRG cells. The four most potent inhibitors of human NTCP were rosiglitazone (IC50 5.1 µM), zafirlukast (IC50 6.5 µM), TRIAC (IC50 6.9 µM), and sulfasalazine (IC50 9.6 µM). Chicago sky blue 6B (IC50 7.1 µM) inhibited both NTCP and ASBT, a distinct though related bile acid transporter. Rosiglitazone, zafirlukast, TRIAC, sulfasalazine, and chicago sky blue 6B reduced HBV/HDV infection in HepaRG cells in a dose-dependent manner. Five out of 1280 clinically approved drugs were identified that inhibit NTCP-mediated bile acid uptake and HBV/HDV infection in vitro.


Subject(s)
Antiviral Agents/pharmacology , Hepatitis B virus/metabolism , Hepatitis B , Hepatitis D , Hepatitis Delta Virus/metabolism , Organic Anion Transporters, Sodium-Dependent/antagonists & inhibitors , Symporters/antagonists & inhibitors , Virus Internalization/drug effects , Animals , Dogs , Hepatitis B/drug therapy , Hepatitis B/metabolism , Hepatitis B/pathology , Hepatitis D/drug therapy , Hepatitis D/metabolism , Hepatitis D/pathology , Humans , Indoles , Lipopeptides/pharmacology , Madin Darby Canine Kidney Cells , Organic Anion Transporters, Sodium-Dependent/genetics , Organic Anion Transporters, Sodium-Dependent/metabolism , Phenylcarbamates , Rosiglitazone/pharmacology , Sulfasalazine/pharmacology , Sulfonamides , Symporters/genetics , Symporters/metabolism , Tosyl Compounds/pharmacology , Triiodothyronine/analogs & derivatives , Triiodothyronine/pharmacology , Trypan Blue/pharmacology
5.
Mol Immunol ; 91: 225-237, 2017 11.
Article in English | MEDLINE | ID: mdl-28968560

ABSTRACT

Most cells are believed to be capable of producing type I interferons (IFN I) as part of an innate immune response against, for instance, viral infections. In macrophages, IFN I is potently induced upon cytoplasmic exposure to foreign nucleic acids. Infection of these cells with herpesviruses leads to triggering of the DNA sensors interferon-inducible protein 16 (IFI16) and cyclic GMP-AMP (cGAMP) synthase (cGAS). Thereby, the stimulator of interferon genes (STING) and the downstream molecules TANK-binding kinase 1 (TBK1) and interferon regulatory factor 3 (IRF3) are sequentially activated culminating in IFN I secretion. Human gamma-herpesviruses, such as Epstein-Barr virus (EBV), exploit B cells as a reservoir for persistent infection. In this study, we investigated whether human B cells, similar to macrophages, engage the cytoplasmic DNA sensing pathway to induce an innate immune response. We found that the B cells fail to secrete IFN I upon cytoplasmic DNA exposure, although they express the DNA sensors cGAS and IFI16 and the signaling components TBK1 and IRF3. In primary human B lymphocytes and EBV-negative B cell lines, this deficiency is explained by a lack of detectable levels of the central adaptor protein STING. In contrast, EBV-transformed B cell lines did express STING, yet both these lines as well as STING-reconstituted EBV-negative B cells did not produce IFN I upon dsDNA or cGAMP stimulation. Our combined data show that the cytoplasmic DNA sensing pathway is dysfunctional in human B cells. This exemplifies that certain cell types cannot induce IFN I in response to cytoplasmic DNA exposure providing a potential niche for viral persistence.


Subject(s)
B-Lymphocytes/immunology , DNA/immunology , Interferon Type I/immunology , B-Lymphocytes/metabolism , B-Lymphocytes/pathology , Cell Line, Transformed , DNA/metabolism , Epstein-Barr Virus Infections/immunology , Epstein-Barr Virus Infections/metabolism , Epstein-Barr Virus Infections/pathology , Female , Herpesvirus 4, Human/immunology , Humans , Interferon Regulatory Factor-3/immunology , Interferon Regulatory Factor-3/metabolism , Interferon Type I/metabolism , Male , Membrane Proteins/immunology , Membrane Proteins/metabolism , Nuclear Proteins/immunology , Nuclear Proteins/metabolism , Nucleotidyltransferases/immunology , Nucleotidyltransferases/metabolism , Phosphoproteins/immunology , Phosphoproteins/metabolism , Protein Serine-Threonine Kinases/immunology , Protein Serine-Threonine Kinases/metabolism
7.
Immunol Rev ; 270(1): 65-77, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26864105

ABSTRACT

Monoclonal antibodies are essential therapeutics and diagnostics in a large number of diseases. Moreover, they are essential tools in all sectors of life sciences. Although the great majority of monoclonal antibodies currently in use are of mouse origin, the use of human B cells to generate monoclonal antibodies is increasing as new techniques to tap the human B cell repertoire are rapidly emerging. Cloned lines of immortalized human B cells are ideal sources of monoclonal antibodies. In this review, we summarize our studies to the regulation of the replicative life span, differentiation, and maturation of B cells that led to the development of a platform that uses immortalization of human B cells by in vitro genetic modification for antibody development. We describe a number of human antibodies that were isolated using this platform and the application of the technique in other species. We also discuss the use of immortalized B cells as antigen-presenting cells for the discovery of tumor neoantigens.


Subject(s)
Antibody-Producing Cells/immunology , Antibody-Producing Cells/metabolism , B-Lymphocytes/immunology , B-Lymphocytes/metabolism , Cell Self Renewal , Animals , Antibodies, Monoclonal/biosynthesis , Antibody Formation/immunology , Antibody-Producing Cells/cytology , Antigen Presentation , Antigen-Presenting Cells/immunology , Antigen-Presenting Cells/metabolism , B-Lymphocytes/cytology , Cell Culture Techniques , Cell Differentiation , Cell Transformation, Neoplastic/genetics , Cell Transformation, Neoplastic/metabolism , Cytidine Deaminase/genetics , Cytidine Deaminase/metabolism , Drug Discovery , Gene Expression Regulation , Germinal Center/cytology , Germinal Center/physiology , Humans , Immunologic Memory , Interleukins/metabolism , Phenotype , Proto-Oncogene Proteins c-bcl-6/genetics , Proto-Oncogene Proteins c-bcl-6/metabolism , STAT3 Transcription Factor/metabolism , STAT5 Transcription Factor/metabolism , Signal Transduction , Vaccines/immunology , bcl-X Protein/genetics , bcl-X Protein/metabolism
8.
Proc Natl Acad Sci U S A ; 111(47): 16820-5, 2014 Nov 25.
Article in English | MEDLINE | ID: mdl-25385586

ABSTRACT

Bispecific antibodies have therapeutic potential by expanding the functions of conventional antibodies. Many different formats of bispecific antibodies have meanwhile been developed. Most are genetic modifications of the antibody backbone to facilitate incorporation of two different variable domains into a single molecule. Here, we present a bispecific format where we have fused two full-sized IgG antibodies via their C termini using sortase transpeptidation and click chemistry to create a covalently linked IgG antibody heterodimer. By linking two potent anti-influenza A antibodies together, we have generated a full antibody dimer with bispecific activity that retains the activity and stability of the two fusion partners.


Subject(s)
Antibodies, Bispecific/biosynthesis , Click Chemistry , Influenza A virus/immunology , Antibodies, Bispecific/chemistry , Antibodies, Bispecific/immunology , B-Lymphocytes/virology , Blotting, Western , Cells, Cultured , Dimerization , Electrophoresis, Polyacrylamide Gel , Humans , Influenza A virus/classification , Surface Plasmon Resonance
9.
Proc Natl Acad Sci U S A ; 111(1): 445-50, 2014 Jan 07.
Article in English | MEDLINE | ID: mdl-24335589

ABSTRACT

The discovery and characterization of broadly neutralizing antibodies (bnAbs) against influenza viruses have raised hopes for the development of monoclonal antibody (mAb)-based immunotherapy and the design of universal influenza vaccines. Only one human bnAb (CR8020) specifically recognizing group 2 influenza A viruses has been previously characterized that binds to a highly conserved epitope at the base of the hemagglutinin (HA) stem and has neutralizing activity against H3, H7, and H10 viruses. Here, we report a second group 2 bnAb, CR8043, which was derived from a different germ-line gene encoding a highly divergent amino acid sequence. CR8043 has in vitro neutralizing activity against H3 and H10 viruses and protects mice against challenge with a lethal dose of H3N2 and H7N7 viruses. The crystal structure and EM reconstructions of the CR8043-H3 HA complex revealed that CR8043 binds to a site similar to the CR8020 epitope but uses an alternative angle of approach and a distinct set of interactions. The identification of another antibody against the group 2 stem epitope suggests that this conserved site of vulnerability has great potential for design of therapeutics and vaccines.


Subject(s)
Antibodies, Neutralizing/immunology , Antibodies, Viral/immunology , Influenza A virus/chemistry , Animals , Antibodies/chemistry , Antibodies, Monoclonal/chemistry , Antibodies, Neutralizing/chemistry , Antibodies, Viral/chemistry , Chromatography, Gel , Enzyme-Linked Immunosorbent Assay , Epitopes/chemistry , Female , Hemagglutinin Glycoproteins, Influenza Virus/chemistry , Humans , Immunologic Memory , Influenza Vaccines/chemistry , Influenza Vaccines/immunology , Kinetics , Mice , Mice, Inbred BALB C , Microscopy, Electron , Models, Molecular , Molecular Conformation , Species Specificity
10.
Methods ; 65(1): 38-43, 2014 Jan 01.
Article in English | MEDLINE | ID: mdl-23867338

ABSTRACT

Antibody based therapies are increasingly applied to prevent and treat human disease. While the majority of antibodies currently on the market are chimeric or humanized antibodies from rodents, the focus has now shifted to the isolation and development of fully human antibodies. By retroviral transduction of B cell lymphoma-6 (BCL-6), which prevents terminal differentiation of B cells and, the anti-apoptotic gene B-cell lymphoma-extra large (Bcl-xL) into primary human B cells we efficiently immortalize antibody-producing B cells allowing the isolation of therapeutic antibodies. Selection of antigen-specific B cell clones was greatly facilitated because the transduced B cells retain surface immunoglobulin expression and secrete immunoglobulin into the culture supernatant. Surface immunoglobulin expression can be utilized to stain and isolate antigen specific B cell clones with labeled antigen. Immunoglobulins secreted in culture supernatant can directly be tested in functional assays to identify unique B cell clones. Here we describe the key features of our Bcl-6/Bcl-xL culture platform (AIMSelect).


Subject(s)
Antibodies, Monoclonal/isolation & purification , B-Lymphocytes/physiology , Animals , Antibodies, Monoclonal/biosynthesis , Cell Culture Techniques , Cell Separation , Cells, Cultured , DNA-Binding Proteins/genetics , Drug Discovery , Genetic Engineering , Humans , Proto-Oncogene Proteins c-bcl-6 , Receptors, Antigen, B-Cell/genetics , Receptors, Antigen, B-Cell/metabolism , bcl-X Protein/genetics
11.
PLoS Pathog ; 9(10): e1003653, 2013.
Article in English | MEDLINE | ID: mdl-24130480

ABSTRACT

Infection of host tissues by Staphylococcus aureus and S. epidermidis requires an unusual family of staphylococcal adhesive proteins that contain long stretches of serine-aspartate dipeptide-repeats (SDR). The prototype member of this family is clumping factor A (ClfA), a key virulence factor that mediates adhesion to host tissues by binding to extracellular matrix proteins such as fibrinogen. However, the biological siginificance of the SDR-domain and its implication for pathogenesis remain poorly understood. Here, we identified two novel bacterial glycosyltransferases, SdgA and SdgB, which modify all SDR-proteins in these two bacterial species. Genetic and biochemical data demonstrated that these two glycosyltransferases directly bind and covalently link N-acetylglucosamine (GlcNAc) moieties to the SDR-domain in a step-wise manner, with SdgB appending the sugar residues proximal to the target Ser-Asp repeats, followed by additional modification by SdgA. GlcNAc-modification of SDR-proteins by SdgB creates an immunodominant epitope for highly opsonic human antibodies, which represent up to 1% of total human IgG. Deletion of these glycosyltransferases renders SDR-proteins vulnerable to proteolysis by human neutrophil-derived cathepsin G. Thus, SdgA and SdgB glycosylate staphylococcal SDR-proteins, which protects them against host proteolytic activity, and yet generates major eptopes for the human anti-staphylococcal antibody response, which may represent an ongoing competition between host and pathogen.


Subject(s)
Bacterial Proteins/immunology , Glycosyltransferases/immunology , Host-Pathogen Interactions/immunology , Methicillin-Resistant Staphylococcus aureus/physiology , Staphylococcal Infections/immunology , Staphylococcus epidermidis/physiology , Virulence Factors/immunology , Animals , Antibodies, Bacterial/genetics , Antibodies, Bacterial/immunology , Bacterial Adhesion/genetics , Bacterial Adhesion/immunology , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Cathepsin G/genetics , Cathepsin G/immunology , Cathepsin G/metabolism , Cell Line, Tumor , Cell Wall/enzymology , Cell Wall/genetics , Cell Wall/immunology , Epitopes/genetics , Epitopes/immunology , Epitopes/metabolism , Female , Glycosyltransferases/genetics , Glycosyltransferases/metabolism , Host-Pathogen Interactions/genetics , Humans , Immunoglobulin G/blood , Immunoglobulin G/immunology , Male , Mice , Repetitive Sequences, Amino Acid , Staphylococcal Infections/enzymology , Staphylococcal Infections/genetics , Virulence Factors/genetics , Virulence Factors/metabolism
12.
Nat Med ; 16(1): 123-8, 2010 Jan.
Article in English | MEDLINE | ID: mdl-20023635

ABSTRACT

The B cell lymphoma-6 (Bcl-6) and Bcl-xL proteins are expressed in germinal center B cells and enable them to endure the proliferative and mutagenic environment of the germinal center. By introducing these genes into peripheral blood memory B cells and culturing these cells with two factors produced by follicular helper T cells, CD40 ligand (CD40L) and interleukin-21 (IL-21), we convert them to highly proliferating, cell surface B cell receptor (BCR)-positive, immunoglobulin-secreting B cells with features of germinal center B cells, including expression of activation-induced cytidine deaminase (AID). We generated cloned lines of B cells specific for respiratory syncytial virus and used these cells as a source of antibodies that effectively neutralized this virus in vivo. This method provides a new tool to study B cell biology and signal transduction through antigen-specific B cell receptors and for the rapid generation of high-affinity human monoclonal antibodies.


Subject(s)
Antibodies, Monoclonal/biosynthesis , B-Lymphocyte Subsets/metabolism , Receptors, Antigen, B-Cell/biosynthesis , Animals , Antibodies, Monoclonal/genetics , Antibodies, Neutralizing/immunology , Antibodies, Viral/immunology , B-Lymphocyte Subsets/immunology , Cell Line , Cytidine Deaminase/biosynthesis , Cytidine Deaminase/genetics , Cytidine Deaminase/metabolism , DNA-Binding Proteins/biosynthesis , DNA-Binding Proteins/genetics , Enzyme Activation , Flow Cytometry , Humans , Immunologic Memory , Phenotype , Proto-Oncogene Proteins c-bcl-6 , Rats , Receptors, Antigen, B-Cell/genetics , Respiratory Syncytial Virus Infections/immunology , Respiratory Syncytial Viruses/immunology , Tetanus Toxin/immunology , Transduction, Genetic , Tumor Necrosis Factor Receptor Superfamily, Member 7/immunology , bcl-X Protein/biosynthesis , bcl-X Protein/genetics
13.
J Immunol ; 180(7): 4805-15, 2008 Apr 01.
Article in English | MEDLINE | ID: mdl-18354204

ABSTRACT

STAT family members have been implicated in regulating the balance between B cell lymphoma (BCL)6 and B lymphocyte induced maturation protein (BLIMP)1 to control plasma cell differentiation. We previously showed that STAT5 induces BCL6 to block plasma cell differentiation and extend the life span of human B cells. The heterogeneity in STAT activation by cytokines and their effects on B cell differentiation prompted us to investigate the effect of STAT3 activation in plasma cell differentiation. First stimulation with IL-21, which promotes plasma cell differentiation, induced robust and prolonged STAT3 activation in primary human B cells. We then investigated effects of direct STAT3 activation on regulation of plasma cell genes, cellular phenotype, and Ig production. Activation of a tamoxifen-regulated STAT3-estrogen receptor fusion protein triggered BLIMP1 mRNA and protein up-regulation, plasma cell phenotypic features, and Ig secretion. When STAT3 was activated by IL-21 in B cells ectopically expressing BCL6, BLIMP1 was up-regulated, but only partial plasma cell differentiation was achieved. Lastly, through coexpression of BCL6 and STAT3-ER, we verified that STAT3 activation functionally mimicked IL-21 treatment and that STAT3-mediated BLIMP1 up-regulation occurred despite high BCL6 expression levels indicating that BCL6 is not the dominant repressor of BLIMP1. Thus, up-regulation of BLIMP1 alone is not sufficient for differentiation of primary human B cells into plasma cells; concomitant down-regulation of BCL6 is absolutely required for completion of the plasma cell differentiation program.


Subject(s)
Cell Differentiation , Down-Regulation , Plasma Cells/cytology , Plasma Cells/metabolism , Repressor Proteins/metabolism , STAT3 Transcription Factor/metabolism , Transcription Factors/metabolism , Up-Regulation , Cell Differentiation/drug effects , Cells, Cultured , DNA-Binding Proteins/metabolism , Humans , Immunoglobulins/immunology , Interleukins/pharmacology , Molecular Mimicry , Phenotype , Phosphorylation/drug effects , Plasma Cells/drug effects , Plasma Cells/immunology , Positive Regulatory Domain I-Binding Factor 1 , Proto-Oncogene Proteins c-bcl-6 , STAT3 Transcription Factor/genetics
14.
Haematologica ; 93(4): 601-4, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18326527

ABSTRACT

CD97 is broadly expressed on hematopoietic cells and is involved in neutrophil migration. Since neutrophils are key regulators in HSC/HPC mobilization, we studied a possible role for CD97 in interleukin-8 and granulocyte-colony stimulating factor-induced HSC/HPC mobilization. Mobilization was absent in mice receiving CD97 mAb followed by interleukin-8, while granulocyte-colony stimulating factor-induced mobilization remained unaltered following anti-CD97 administration. Furthermore, combined administration of CD97 mAb and IL-8 induced a significant reduction in the neutrophilic compartment. We hypothesize that the absence of interleukin-8-induced HSC/HPC mobilization after CD97 mAb administration is due to its effect on neutrophil function.


Subject(s)
Antibodies, Monoclonal/pharmacology , Chemotaxis, Leukocyte/drug effects , Granulocyte Colony-Stimulating Factor/pharmacology , Hematopoietic Stem Cell Mobilization/methods , Interleukin-8/pharmacology , Membrane Glycoproteins/physiology , Animals , Antibodies, Monoclonal/administration & dosage , Colony-Forming Units Assay , Drug Administration Schedule , Granulocyte Colony-Stimulating Factor/administration & dosage , Interleukin-8/administration & dosage , Leukocyte Count , Male , Membrane Glycoproteins/antagonists & inhibitors , Membrane Glycoproteins/immunology , Mice , Mice, Inbred BALB C , Neutrophils/physiology , Receptors, G-Protein-Coupled , Recombinant Fusion Proteins/pharmacology
15.
Eur J Immunol ; 37(10): 2797-802, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17823986

ABSTRACT

The EGF-TM7 F4/80 is a defining marker of murine macrophage populations. Applying flow cytometric analysis using the newly generated mAb A10, and quantitative real-time PCR, we here report the surprising observation that the human ortholog of F4/80, EGF-like module containing mucin-like hormone receptor (EMR)1, is absent on mononuclear phagocytic cells including monocytes, macrophages, and myeloid dendritic cells. Unexpectedly, we found that EMR1 expression is restricted to eosinophilic granulocytes, where expression is overlapping with the eotaxin receptor CCR3 and the immunoglobulin-like lectin Siglec-8. Absence on other leukocytes, including basophils, implies that EMR1 is a highly specific marker for eosinophils in humans.


Subject(s)
Antigens, Differentiation/metabolism , Eosinophils/immunology , Eosinophils/metabolism , Membrane Glycoproteins/metabolism , Mucins/metabolism , Receptors, G-Protein-Coupled/metabolism , Structural Homology, Protein , Animals , Antibodies, Monoclonal/biosynthesis , Antigens, Differentiation/chemistry , Biomarkers/metabolism , CHO Cells , Calcium-Binding Proteins , Cells, Cultured , Cricetinae , Cricetulus , Humans , Macaca mulatta , Membrane Glycoproteins/biosynthesis , Membrane Glycoproteins/chemistry , Membrane Glycoproteins/genetics , Mice , Mucins/biosynthesis , Mucins/chemistry , Mucins/genetics , Pan troglodytes , Papio , Pongo pygmaeus , Receptors, G-Protein-Coupled/biosynthesis , Receptors, G-Protein-Coupled/chemistry , Receptors, G-Protein-Coupled/genetics , Saguinus
16.
FASEB J ; 20(14): 2582-4, 2006 Dec.
Article in English | MEDLINE | ID: mdl-17068111

ABSTRACT

The epidermal growth factor (EGF)-TM7 receptors CD97, EMR1, EMR2, EMR3, and EMR4 form a group of adhesion class heptahelical molecules predominantly expressed by cells of the immune system. These receptors bind cellular ligands through EGF-like domains, localized N-terminal to a large extracellular region. Remarkably, EMR2 possesses a chimeric structure with a seven-span transmembrane (TM7) region most related to EMR3 and an EGF domain region nearly identical to CD97. By comparing EGF-TM7 receptors in primates and dogs, we identified an intriguing pattern of concerted evolution, apparently mediated by gene conversion, among EMR2 and the oppositely orientated and physically adjacent genes CD97 and EMR3. This concerted evolution has continuously maintained the chimeric structure of EMR2 since early mammal radiation. Most highly conserved between EMR2 and CD97 is the fourth EGF domain, which mediates binding to chondroitin sulfate, a ligand specificity shared by both receptors. Another ligand, CD55, is bound effectively only by CD97. We show that different molecular mechanisms (mutations vs. alternative splicing) prevent CD55 binding by EMR2 in hominoids. Our findings illustrate how various and partially opposing evolutionary events have shaped the structure and ligand specificity of a modern mammalian gene family.


Subject(s)
Evolution, Molecular , Receptors, G-Protein-Coupled/genetics , Amino Acid Sequence , Animals , Callithrix , Dogs , Macaca mulatta , Molecular Sequence Data , Pan troglodytes , Papio hamadryas , Pongo pygmaeus , Protein Conformation , Protein Structure, Tertiary , Receptors, G-Protein-Coupled/chemistry , Saguinus
17.
J Exp Med ; 203(4): 897-906, 2006 Apr 17.
Article in English | MEDLINE | ID: mdl-16549596

ABSTRACT

Secondary T cell responses are enhanced because of an expansion in numbers of antigen-specific (memory) cells. Using major histocompatibility complex class II tetramers we have tracked peptide-specific endogenous (non-T cell receptor transgenic) CD4 memory T cells in normal and in costimulation-deficient mice. CD4 memory T cells were detectable after immunization for more than 200 days, although decay was apparent. Memory cells generated in CD40 knockout mice by immunization with peptide-pulsed wild-type dendritic cells survived in the absence of CD40 and proliferated when boosted with peptide (plus adjuvant) in a CD40-independent fashion. However, differentiation of the memory cells into cytokine-producing effector cells did not occur in the absence of CD40. The data indicate that memory cells can be generated without passing through the effector cell stage.


Subject(s)
CD4-Positive T-Lymphocytes/cytology , CD4-Positive T-Lymphocytes/immunology , CD40 Antigens/physiology , Cell Differentiation , Immunologic Memory , Amino Acid Sequence , Animals , CD40 Antigens/genetics , Cell Differentiation/immunology , Cell Proliferation , Cell Survival/immunology , Cells, Cultured , Dendritic Cells/immunology , Immunophenotyping , Mice , Mice, Inbred C57BL , Mice, Knockout , Molecular Sequence Data
18.
Arthritis Rheum ; 52(2): 442-50, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15693006

ABSTRACT

OBJECTIVE: EMR2 and CD97 are closely related members of the epidermal growth factor (EGF)-TM7 family of adhesion class 7-span transmembrane (TM7) receptors. Chondroitin sulfates (CS) have recently been identified as ligands for EMR2 and CD97. CS have been implicated in the pathogenesis of rheumatoid arthritis (RA). We undertook this study to determine the expression of EMR2 and the distribution of EMR2 and CD97 ligands within RA synovial tissue (ST). METHODS: ST samples were obtained by arthroscopy from 19 patients with RA, 13 patients with inflammatory osteoarthritis (OA), and 13 patients with reactive arthritis (ReA). Immunohistochemistry was performed with a monoclonal antibody against EMR2, and stained STs were analyzed by digital image analysis. Coexpression of EMR2 with cell lineage- and activation-specific markers was determined by double immunofluorescence microscopy. To evaluate the expression of EMR2 and CD97 ligands in RA synovium, binding assays were performed using EMR2- and CD97-specific multivalent fluorescent probes. RESULTS: EMR2 expression in the synovial sublining was found to be significantly higher in RA patients compared with OA and ReA control patients. Most EMR2+ cells were macrophages and dendritic cells expressing costimulatory molecules and tumor necrosis factor alpha. Dermatan sulfate was shown to be the ligand of the largest isoforms of EMR2 and CD97 in rheumatoid synovium. In addition, the smaller isoforms of CD97, but not those of EMR2, bound CD55 on fibroblast-like synoviocytes. CONCLUSION: The EGF-TM7 receptors EMR2 and CD97 are abundantly expressed on myeloid cells in ST of RA patients where their cognate ligands dermatan sulfate and CD55 are detected. These results suggest that these interactions may facilitate the retention of activated macrophages in the synovium.


Subject(s)
Arthritis, Rheumatoid/metabolism , Dermatan Sulfate/analysis , Epidermal Growth Factor/analysis , Receptors, G-Protein-Coupled/analysis , Synovial Membrane/chemistry , Aged , Antigens, CD , CD55 Antigens/analysis , Female , Fluorescent Dyes , Humans , Immunohistochemistry , Ligands , Male , Membrane Glycoproteins/analysis , Microscopy, Interference , Middle Aged , Osteoarthritis/metabolism , Prohibitins
19.
J Leukoc Biol ; 77(1): 112-9, 2005 Jan.
Article in English | MEDLINE | ID: mdl-15498814

ABSTRACT

The EGF-TM7 receptors CD97 and EMR2 are heptahelical molecules predominantly expressed on leukocytes. A characteristic of these receptors is their ability to interact with cellular ligands via the N-terminal epidermal growth factor (EGF)-like domains. The first two EGF domains of CD97 (but not EMR2) bind CD55 (decay-accelerating factor), while the fourth EGF domain of both CD97 and EMR2 interacts with the glycosaminoglycan chondroitin sulfate (CS). Using fluorescent beads coated with soluble recombinant CD97 and EMR2 protein, and isoform-specific monoclonal antibodies, we have determined the cellular and molecular characteristics of the interaction with CS. The fourth EGF domain of CD97 and EMR2 is expressed on activated lymphocytes and myeloid cells, whereas the ligand is specifically found on B cells within the peripheral blood. The interaction between CD97/EMR2 and CS may therefore play a role in the interaction of activated T cells, dendritic cells, and macrophages with B cells.


Subject(s)
B-Lymphocytes/metabolism , Chondroitin Sulfates/metabolism , Epidermal Growth Factor/metabolism , Leukocytes/metabolism , Membrane Glycoproteins/metabolism , Antibodies, Monoclonal/metabolism , Antigens, CD , CD55 Antigens/metabolism , Cells, Cultured , Dendritic Cells/metabolism , Humans , Ligands , Lymphocyte Activation , Macrophages/metabolism , Myeloid Cells/metabolism , Protein Isoforms , Receptors, G-Protein-Coupled
20.
Immunogenetics ; 55(10): 655-66, 2004 Jan.
Article in English | MEDLINE | ID: mdl-14647991

ABSTRACT

With the human and mouse genome projects now completed, the receptor repertoire of mammalian cells has finally been elucidated. The EGF-TM7 receptors are a family of class B seven-span transmembrane (TM7) receptors predominantly expressed by cells of the immune system. Within the large TM7 superfamily, the molecular structure and ligand-binding properties of EGF-TM7 receptors are unique. Derived from the processing of a single polypeptide, they are expressed at the cell surface as heterodimers consisting of a large extracellular region associated with a TM7 moiety. Through a variable number of N-terminal epidermal growth factor (EGF)-like domains, EGF-TM7 receptors interact with cellular ligands such as CD55 and chondroitin sulfate. Recent in vivo studies demonstrate a role of the EGF-TM7 receptor CD97 in leukocyte migration. The different number of EGF-TM7 genes in man compared with mice, the chimeric nature of EMR2 and the inactivation of human EMR4 point toward a still-evolving receptor family. Here we discuss the currently available information on this intriguing receptor family.


Subject(s)
Epidermal Growth Factor/genetics , Membrane Proteins/genetics , Multigene Family , Amino Acid Sequence , Animals , Cell Movement , Epidermal Growth Factor/chemistry , Epidermal Growth Factor/physiology , Evolution, Molecular , GTP-Binding Proteins/physiology , Humans , Membrane Proteins/chemistry , Membrane Proteins/classification , Membrane Proteins/physiology , Mice , Models, Molecular , Molecular Sequence Data , Muscle, Smooth/cytology , Muscle, Smooth/metabolism , Myeloid Cells/metabolism , Primates/genetics , Protein Conformation , Protein Structure, Tertiary , Receptors, G-Protein-Coupled/genetics , Sequence Alignment , Sequence Homology, Amino Acid , Signal Transduction , Species Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...